We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 61-80 of 136 results
  1. An adapted protocol to derive microglia from stem cells and its application in the study of CSF1R-related disorders

    Background

    Induced pluripotent stem cell-derived microglia (iMGL) represent an excellent tool in studying microglial function in health and disease....

    Marie-France Dorion, Diana Casas, ... Luke M. Healy in Molecular Neurodegeneration
    Article Open access 05 April 2024
  2. Comprehensive gene expression meta-analysis identifies signature genes that distinguish microglia from peripheral monocytes/macrophages in health and glioma

    Monocytes/macrophages have begun to emerge as key cellular modulators of brain homeostasis and central nervous system (CNS) disease. In the healthy...

    Verena Haage, Marcus Semtner, ... David H. Gutmann in Acta Neuropathologica Communications
    Article Open access 14 February 2019
  3. Cognate microglia–T cell interactions shape the functional regulatory T cell pool in experimental autoimmune encephalomyelitis pathology

    Microglia, the parenchymal brain macrophages of the central nervous system, have emerged as critical players in brain development and homeostasis....

    Zhana Haimon, Gal Ronit Frumer, ... Steffen Jung in Nature Immunology
    Article 01 December 2022
  4. Temporal tracking of microglial and monocyte single-cell transcriptomics in lethal flavivirus infection

    As the resident parenchymal myeloid population in the central nervous system (CNS), microglia are strategically positioned to respond to neurotropic...

    Alanna G. Spiteri, Claire L. Wishart, ... Nicholas J. C. King in Acta Neuropathologica Communications
    Article Open access 04 April 2023
  5. Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia

    Neurodegeneration occurring in multiple sclerosis (MS) contributes to the progression of disability. It is therefore important to identify and...

    Yifei Dong, Charlotte D’Mello, ... V. Wee Yong in Nature Neuroscience
    Article 18 February 2021
  6. Epigenome-wide association study of bronchopulmonary dysplasia in preterm infants: results from the discovery-BPD program

    Background

    Bronchopulmonary dysplasia (BPD) is a lung disease in premature infants caused by therapeutic oxygen supplemental and characterized by...

    Xuting Wang, Hye-Youn Cho, ... Douglas A. Bell in Clinical Epigenetics
    Article Open access 28 April 2022
  7. APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases

    ApoE is the major lipid and cholesterol carrier in the CNS. There are three major human polymorphisms, apoE2, apoE3, and apoE4, and the genetic...

    Rosalía Fernández-Calle, Sabine C. Konings, ... Tomas Deierborg in Molecular Neurodegeneration
    Article Open access 24 September 2022
  8. The relationship between extreme inter-individual variation in macrophage gene expression and genetic susceptibility to inflammatory bowel disease

    The differentiation of resident intestinal macrophages from blood monocytes depends upon signals from the macrophage colony-stimulating factor...

    Claire L. O’Brien, Kim M. Summers, ... Paul Pavli in Human Genetics
    Article Open access 29 February 2024
  9. Immune-related prognosis biomarkers associated with osteosarcoma microenvironment

    Background

    Osteosarcoma is a highly aggressive bone tumor that most commonly affects children and adolescents. Treatment and outcomes for osteosarcoma...

    Weifeng Hong, Hong Yuan, ... Liheng Ma in Cancer Cell International
    Article Open access 16 March 2020
  10. Integrative in situ map** of single-cell transcriptional states and tissue histopathology in a mouse model of Alzheimer’s disease

    Complex diseases are characterized by spatiotemporal cellular and molecular changes that may be difficult to comprehensively capture. However,...

    Hu Zeng, Jiahao Huang, ... **ao Wang in Nature Neuroscience
    Article 02 February 2023
  11. APOE4 impairs the microglial response in Alzheimer’s disease by inducing TGFβ-mediated checkpoints

    The APOE4 allele is the strongest genetic risk factor for late-onset Alzheimer’s disease (AD). The contribution of microglial APOE4 to AD...

    Zhuoran Yin, Neta Rosenzweig, ... Oleg Butovsky in Nature Immunology
    Article 25 September 2023
  12. Human stem cell models to study host–virus interactions in the central nervous system

    Advancements in human pluripotent stem cell technology offer a unique opportunity for the neuroimmunology field to study host–virus interactions...

    Oliver Harschnitz, Lorenz Studer in Nature Reviews Immunology
    Article 04 January 2021
  13. Single-cell profiling of human dura and meningioma reveals cellular meningeal landscape and insights into meningioma immune response

    Background

    Recent investigations of the meninges have highlighted the importance of the dura layer in central nervous system immune surveillance...

    Anthony Z. Wang, Jay A. Bowman-Kirigin, ... Gavin P. Dunn in Genome Medicine
    Article Open access 10 May 2022
  14. Single-cell transcriptomics of the ventral posterolateral nucleus-enriched thalamic regions from HSV-1-infected mice reveal a novel microglia/microglia-like transcriptional response

    Background

    Microglia participate in the immune response upon central nervous system (CNS) infections. However, the role of these cells during herpes...

    Olus Uyar, Juan Manuel Dominguez, ... Guy Boivin in Journal of Neuroinflammation
    Article Open access 06 April 2022
  15. Human Huntington’s disease pluripotent stem cell-derived microglia develop normally but are abnormally hyper-reactive and release elevated levels of reactive oxygen species

    Background

    Neuroinflammation may contribute to the pathogenesis of Huntington’s disease, given evidence of activated microglia and elevated levels of...

    Grace C. O’Regan, Sahar H. Farag, ... Ralph Andre in Journal of Neuroinflammation
    Article Open access 19 April 2021
  16. Profiling peripheral nerve macrophages reveals two macrophage subsets with distinct localization, transcriptome and response to injury

    While CNS microglia have been extensively studied, relatively little is known about macrophages populating the peripheral nervous system. Here we...

    Elke Ydens, Lukas Amann, ... Martin Guilliams in Nature Neuroscience
    Article 13 April 2020
  17. BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia

    Background

    The BIN1 locus contains the second-most significant genetic risk factor for late-onset Alzheimer’s disease. BIN1 undergoes alternate...

    Ari Sudwarts, Supriya Ramesha, ... Srikant Rangaraju in Molecular Neurodegeneration
    Article Open access 07 May 2022
  18. Microglial-associated responses to comorbid amyloid pathology and hyperhomocysteinemia in an aged knock-in mouse model of Alzheimer’s disease

    Background

    Elevated blood homocysteine levels, termed hyperhomocysteinemia (HHcy), is a prevalent risk factor for Alzheimer’s disease (AD) in elderly...

    David J. Braun, Edgardo Dimayuga, ... Linda J. Van Eldik in Journal of Neuroinflammation
    Article Open access 17 September 2020
  19. The cytokines interleukin-6 and interferon-α induce distinct microglia phenotypes

    Background

    Elevated production of the cytokines interleukin (IL)-6 or interferon (IFN)-α in the central nervous system (CNS) is implicated in the...

    Phillip K. West, Andrew N. McCorkindale, ... Markus J. Hofer in Journal of Neuroinflammation
    Article Open access 16 April 2022
  20. Neural In Vitro Models for Studying Substances Acting on the Central Nervous System

    Animal models have been greatly contributing to our understanding of physiology, mechanisms of diseases, and toxicity. Yet, their limitations due to,...
    Ellen Fritsche, Julia Tigges, ... Barbara Viviani in Organotypic Models in Drug Development
    Chapter 2020
Did you find what you were looking for? Share feedback.